Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 1;1(6):588-599.
doi: 10.1210/js.2016-1080.

Management of Asymptomatic Patients With Positive Coronary Artery Calcium Scans

Mark R Burge  1 , R Philip Eaton  1 , George Comerci  2 , Brendan Cavanaugh  3 , Barry Ramo  3 , David S Schade  1
Affiliations
Review

Management of Asymptomatic Patients With Positive Coronary Artery Calcium Scans

Mark R Burge et al. J Endocr Soc. .

Abstract

Background: The widespread availability of the coronary artery calcium scan to diagnose coronary artery atheroma semiquantitatively and its prognostic significance has frequently resulted in a difficult therapeutic decision for physicians caring for asymptomatic patients.

Patients and risk factors: Of particular concern are patients over 40 years of age and young adults characterized by multiple cardiovascular risk factors. The correct prognostic interpretation of coronary artery calcium scores and the potential benefits and risks of various therapeutic modalities need to be understood.

Conclusion: This review describes the therapeutic choices available to endocrinologists and provides recommendations for various treatment options.

Keywords: LDL cholesterol; calcium scan; coronary angiography; heart disease; statins; stress testing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cumulative incidence of any coronary event over 4 to 5 years of follow-up after receiving a CAC score evaluation among 6722 multiethnic men and women without preexisting cardiovascular disease in the MESA study. Adapted from Detrano et al. [23].
Figure 2.
Figure 2.
The importance of both the calcium score and the number of risk factors in determining the prognosis of individuals. The composite scores may be easily obtained by using the MESA risk calculator as described in the text. Adapted from Silverman et al. [25]. The risk factors considered to construct the bar graphs were: current smoking, hypertension, diabetes, and a family history of coronary heart disease. Definitions of these risk factors are provided in Silverman et al. [25].
Figure 3.
Figure 3.
Treatment recommendations for an asymptomatic patient presenting with a positive calcium scan. The algorithm is based on aggressively addressing the four main cardiovascular risk factors, including abnormal lipids, hypertension, diabetes, and smoking through lifestyle improvement and medication prescription and adherence. EKG, electrocardiogram; hsCRP, high-sensitivity C-reactive protein.
See this image and copyright information in PMC

References

    1. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, Bild DE, Shea S, Liu K, Watson KE, Folsom AR, Khera A, Ayers C, Mahabadi AA, Lehmann N, Jöckel KH, Moebus S, Carr JJ, Erbel R, Burke GL. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66(15):1643–1653. - PMC - PubMed
    1. Tota-Maharaj R, Blaha MJ, McEvoy JW, Blumenthal RS, Muse ED, Budoff MJ, Shaw LJ, Berman DS, Rana JS, Rumberger J, Callister T, Rivera J, Agatston A, Nasir K. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J. 2012;33(23):2955–2962. - PubMed
    1. Eaton RP, Burge MR, Comerci G, Cavanaugh B, Ramo B, Schade DS. Abnormal coronary artery calcium scans in asymptomatic patients. Am J Med. 2017;130(4):394–397. - PubMed
    1. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group . Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516. - PubMed
    1. Sedlis SP, Hartigan PM, Teo KK, Maron DJ, Spertus JA, Mancini GBJ, Kostuk W, Chaitman BR, Berman D, Lorin JD, Dada M, Weintraub WS, Boden WE; COURAGE Trial Investigators . Effect of PCI on long-term survival in patients with stable ischemic heart disease. N Engl J Med. 2015;373(20):1937–1946. - PMC - PubMed

LinkOut - more resources